Effects of Obesity and Weight Loss on Soluble CD40L Levels [6]

JAMA

Volumn 289, Issue 14, 2003, Pages 1781-1782

  Desideri, Giovambattista ^a   Ferri, Claudio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; CD40 LIGAND; DRUG DERIVATIVE; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN F2 ALPHA;

CALORIC RESTRICTION; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; HUMAN; LETTER; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; WEIGHT REDUCTION; BLOOD; DIET THERAPY; MALE; MIDDLE AGED; NOTE; PHYSIOLOGY;

CD40 LIGAND; DINOPROST; F2-ISOPROSTANES; HUMANS; MALE; MIDDLE AGED; OBESITY; PLATELET ACTIVATION; WEIGHT LOSS;

EID: 0037502808     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.14.1781     Document Type: Letter

References (6)

1. Davi G, Guagnano MT, Ciabattoni G, et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA. 2002;288:2008-2014.
2. Cipollone F, Mezzetti A, Porreca E, et al. Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy. Circulation. 2002;106:399-402.
3. Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood. 2001;98:1047-1054.
4. Andrè P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation. 2002;106:896-899.
5. Ferri C, Desideri G, Valenti M, et al. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension. 1999;34(4 pt 1):568-573.
6. Crepaldi G, Belfiore F, Bosello O, et al. Italian Consensus Conference-overweight, obesity and health. Int J Obes. 1991;15:781-790.